(Q54812506)

English

CHLA-79

cell line

CHLA_79

In more languages

Statements

1 reference

Cellosaurus release 49

13 July 2024

cancer cell line

1 reference

Cellosaurus release 49

13 July 2024

described by source

Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.

1 reference

Cellosaurus release 49

13 July 2024

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma

1 reference

Cellosaurus release 49

13 July 2024

Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines

1 reference

Cellosaurus release 49

13 July 2024

Mutations in PIK3CA are infrequent in neuroblastoma

1 reference

Cellosaurus release 49

13 July 2024

Identification of ALK as a major familial neuroblastoma predisposition gene

1 reference

Cellosaurus release 49

13 July 2024

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

1 reference

Cellosaurus release 49

13 July 2024

Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations

1 reference

Cellosaurus release 49

13 July 2024

established from medical condition

1 reference

Cellosaurus release 49

13 July 2024

derived from organism type

unknown value

2 references

Cellosaurus release 44

7 January 2023

Cellosaurus release 49

13 July 2024

Identifiers

1 reference

Cellosaurus release 49

13 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54812506&oldid=2205409446"